Department of Cardiovascular, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, P.R. China.
Mol Med Rep. 2023 Sep;28(3). doi: 10.3892/mmr.2023.13059. Epub 2023 Jul 28.
Cardiovascular disease (CVD) is a common chronic clinical condition and is the main cause of death in humans worldwide. Understanding the genetic and molecular mechanisms involved in the development of CVD is essential to develop effective prevention strategies and therapeutic measures. An increasing number of CVD‑related genetic studies have been conducted, including those on the potential roles of microRNAs (miRs). These studies have demonstrated that miR‑378 is involved in the pathological processes of CVD, including those of myocardial infarction, heart failure and coronary heart disease. Despite the potential importance of miR‑378 CVD, a comprehensive summary of the related literature is lacking. Thus, the present review aimed to summarize the findings of previous studies on the roles and mechanisms of miR‑378 in a variety of CVDs and provide an up‑to date basis for further r research targeting the prevention and treatment of CVDs.
心血管疾病(CVD)是一种常见的慢性临床病症,也是全球人类死亡的主要原因。了解 CVD 发展过程中涉及的遗传和分子机制对于开发有效的预防策略和治疗措施至关重要。越来越多的与 CVD 相关的遗传研究已经开展,包括 microRNAs(miRs)的潜在作用。这些研究表明,miR-378 参与 CVD 的病理过程,包括心肌梗死、心力衰竭和冠心病。尽管 miR-378 在 CVD 中具有潜在的重要性,但相关文献的综合总结却很缺乏。因此,本综述旨在总结 miR-378 在多种 CVD 中的作用和机制的研究结果,并为进一步针对 CVD 的预防和治疗的研究提供最新依据。